Immunogenicity and Safety of the DTaP-IPV/Hib Vaccine SP0204) Given as Three-dose Primary and One-dose Booster Vaccinations Versus Co-administration of DTaP-IPV Vaccine (DD-687) and Hib Vaccine (DF-098) in Infants in Japan
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hib vaccine conjugate; Pertussis diptheria tetanus poliovirus vaccine (Squarekids)
- Indications Bacterial meningitis; Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 25 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.
- 19 Jul 2016 Planned End Date changed from 1 Nov 2016 to 1 Jan 2017.